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Introduction: Up to 50% of adults with congestive heart failure (CHF) and left ventricular 
dysfunction demonstrate Cheyne–Stokes respiration (CSR), although the mechanisms remain 
controversial. Because CSR has been minimally studied in children, we sought to assess the 
prevalence of CSR in children with low and high output cardiac failure. We hypothesized that 
the existence of CSR only in children with low output CHF would support the importance 
of circulatory delay as a CSR mechanism. Methods: Thirty patients participated: 10 children 
with CHF , 10 matched children with no heart disease, and 10 adults with CHF . All participants 
underwent an in-laboratory polysomnographic sleep study. Results: CHF children’s average 
age (±SEM) was 3.6 ± 2.1 years vs. 3.7 ± 2 years in the age-matched control group.  The average 
ejection fraction of three children with low output CHF was 22 ± 6.8%. The remaining seven 
had normal-high cardiac output. Compared to control children, CHF children were tachypneic 
and tachycardic during stable sleep (55.1 ± 6.7 vs. 26.9 ± 3 breath/min and 127 .6 ± 8.7 vs. 
97 .6 ± 6.9 beats/min, respectively, p < 0.05 for both).  They had shorter total sleep time (195 ± 49 
vs. 373 ± 16 min, p < 0.05) with a low sleep efficiency of 65.6 ± 6%. None of the children had a 
pattern of CSR at any time during the studies while the adults with CHF had 40% prevalence of 
CSR. Conclusions:  The complete absence of CSR in our sample of children with CHF compared 
to the 40% prevalence in the adults with CHF we studied, suggests that CSR may be an age-
dependent phenomenon. Thus, we speculate that regardless of the exact mechanism which 
drives CSR, age is an over-riding factor.
Keywords: Cheyne–Stokes respiration, congestive heart failure, children, age
Edited by:
Eliot S. Katz, Harvard Medical School, 
USA
Reviewed by:
Brian McGinley,  
Johns Hopkins University, USA
Ignacio Tapia,  
The Children’s Hospital of Philadelphia, 
USA
*Correspondence:
Avivit Peer, Sleep Laboratory/Oncology 
Division, Rambam Medical Center, 
Haifa 31096, Israel.
e-mail: a_peer@rambam.health.gov.il
of the mechanism, aging is known to be a major risk factor for CSR 
occurrence among adults with CHF (Bixler et al., 1998; Javaheri 
et al., 1998; Sin et al., 1999).
Cheyne–Stokes respiration is associated with sleep disruption 
and its most immediate consequences include sleep fragmentation 
and impairment of neurocognitive function (Cheshire et al., 1992; 
Hanly and Zuber-Khokhar, 1995). In addition, there are increas-
ing data that CSR may alter the natural history of the heart failure 
(Lanfranchi et al., 1999; Sin et al., 2000). Intermittent hypoxemia 
due to apnea, and recurrent arousal from sleep associated with 
hyperpnea, are related to the increased sympathetic nervous system 
activity which in turn is associated with increased mortality in 
patients with CHF (Cohn et al., 1984; Somers et al., 1989, 1993). 
Furthermore, it has been shown that the existence of CSR in patients 
with CHF has prognostic value, and specific treatment directed 
for the respiratory abnormality (i.e., continuous positive airway 
pressure – CPAP) improves cardiac function, quality of life, and 
perhaps prognosis (Javaheri, 2000; Bradley et al., 2005).
In contrast to systolic heart failure in adults, in children the 
common causes of CHF are congenital heart defects such as large 
ventricular septal defects. In other cases such as myocarditis and 
cardiomyopathies, children also demonstrate low output CHF. 
Interestingly, despite a relatively high prevalence of CHF in children 
with heart disease (27%) (Sommers et al., 2005), aside form one 
IntroductIon
Cheyne–Stokes respiration (CSR) is a form of periodic breathing 
characterized by recurrent episodes of central apnea, alternating 
with periods of hyperpnea. Tidal volumes during these events have 
a typical crescendo-decrescendo appearance. CSR is associated with 
congestive heart failure (CHF) and has been reported to develop 
in approximately 40–50% of adult patients with left ventricular 
ejection fraction (LVEF) of less than 40%. Most of the existing data 
from adult patients suggest that the occurrence of CSR is a marker 
of increasing CHF severity. Unlike obstructive sleep apnea (OSA) 
which is considered to be a cause of CHF, CSR is more likely to be a 
consequence of CHF (Javaheri et al., 1998; Naughton and Bradley, 
1998; Sin et al., 1999; Bradley and Floras, 2003). The precise patho-
physiological mechanisms leading to the development of CSR are 
somewhat controversial. Proposed mechanisms include increased 
central nervous system sensitivity to changes in arterial PCO2 and 
PO2, a decrease in total body stores of PCO2 and PO2, with falls in 
the partial pressure of arterial PCO2 below the apnea threshold 
in response to changes in ventilation, catecholamine hypersecre-
tion, dynamic upper airway instability, pulmonary congestion, 
hypoxemic events, hyper-arousability/arousals from sleep and an 
increased circulatory time in patients with CHF (Quaranta et al., 
1997; Javaheri et al., 1998; Naughton and Bradley, 1998; Sin et al., 
1999; Bradley and Floras, 2003; Ryan and Bradley, 2005). Regardless Frontiers in Psychiatry  |  Sleep Disorders    September 2010  | Volume 1  | Article 133  |  2
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electroencephalographic frequency change for 3 s in non-rapid 
eye movement (NREM) sleep and any such change associated with 
body movement or increase in electromyogram during rapid eye 
movement (REM) sleep.
Respiratory  events  were  scored  according  to  the  common 
practice for measurement in children with some modifications 
(American Thoracic Society Task Force, 1996). Apneas were defined 
as the complete cessation of breathing for at least two breath cycles, 
and hypopneas, as any notable decrement in ventilation for at least 
two breath cycles, if the hypopnea was associated with a decrease of 
at least 3% in SpO2, an increase in ETCO2 or arousal from sleep. In 
particular, obstructive apnea was defined as cessation of airflow at 
the nose and the mouth, as measured by the thermistor and the cap-
nograph, with continued respiratory effort (movements of the rib 
cage and the abdomen) for at least two breaths. In the adults group 
the respiratory events were scored according to the common prac-
tice in this age group, i.e., “Chicago Criteria” (American Academy 
of Sleep Medicine Task Force, 1999).Central apnea was defined as 
the absence of airflow at both the nose and mouth as measured 
by the thermistor and the capnograph, associated with absence 
of movement of the chest and abdominal walls. Mixed apnea was 
defined as an apnea with both central and obstructive components 
in any order, with the central component lasting ≥3 s. The recur-
rent central events alternating with a crescendo–decrescendo pat-
tern of tidal volume were defined as CSR, at epoch lengths of 0.5, 
1, 2, and 5 min. Hypopnea was further characterized as obstruc-
tive if the reduction in airflow was associated with paradoxical 
chest and abdominal movement, or central if associated with an 
in-phase reduction in the amplitude of the chest and abdominal 
signals (Moser et al., 1994). The subjects were also monitored and 
recorded on audio/videotape using an infrared video camera. Each 
participant was continuously observed by a technician during the 
overnight recording.
data analysIs
All records were scored by both a blinded sleep technologist and the 
investigators (independently) to search for CSR, in various time-
scale windows. All values are shown as mean ± SEM. The three 
groups were compared using one way ANOVA. Children with and 
without CHF were compared by two tailed t-test. p < 0.05 was 
considered of statistical significance.
results
subjects characterIstIcs
A total of 20 children and 10 adults were studied. The children with 
and without CHF were matched in terms of age (3.6 ± 2.1 years vs. 
3.7 ± 2 years) and gender (five males/five females vs. four males/
six females). Seven of the CHF children were infants at an average 
age of 0.22 ± 0.04 years, with severe high output cardiac failure as 
a result of congenital septal defects (large VSD ± ASD) in some, 
along with valvular insufficiency and moderate to severe pulmonary 
hypertension. Six/seven children underwent surgical intervention 
for correction of their septal defect. Three were children at an aver-
age age of 11.5 ± 4.4 years, with severe low output cardiac failure 
as a result of dilated cardiomyopathy with mean left ventricle ejec-
tion fraction of 22 ± 6.8% (similar to the 26.5 ± 3.1% in the adult 
CHF group). Two of them underwent cardiac transplantation at a 
case report (Hoch and Barth, 2001), CSR breathing pattern has not 
been reported in pediatric patients with CHF to our knowledge. It is 
not clear whether CSR in children with CHF has not been observed 
because its presence has not been assessed adequately or because 
specific age-related mechanisms in children protect against this 
respiratory pattern. Thus, in the current study we sought to assess 
the prevalence of CSR in children with low and high output cardiac 
failure to provide insights into the relative importance of the above 
pathophysiological mechanisms. We hypothesized that the exist-
ence of CSR only in children with low output CHF would support 
the importance of circulatory delay as a CSR mechanism.
MaterIals and Methods
subjects
We conducted a prospective observational case–control study in 
which we studied a population consisting of thirty patients recruited 
as follows: 10 consecutive children with CHF were recruited via the 
pediatric cardiology department clinics, Meyer Children’s Hospital 
(Haifa, Israel). Ten additional children without CHF were recruited 
as controls (matched by age and gender) from the sleep clinic. They 
were referred to the sleep clinic due to snoring and potential apnea, 
but had no known heart abnormality based on a thorough history 
and physical examination. Ten adults with an established diagnosis 
of CHF referred to the Sleep Laboratory due to suspected sleep 
disordered breathing were recruited as well, to serve as controls 
with cardiac disease. All of the children with CHF underwent a 
careful cardiac evaluation with a diagnosis of CHF established by a 
cardiologist as defined by characteristic symptoms and testing (rest-
ing tachypnea and tachycardia, pulmonary congestion etc.). Their 
workup included the following: medical history, physical examina-
tion, ECG, chest radiography, and two-  dimensional echocardiogra-
phy. Following their cardiac evaluation an in-lab polysomnographic 
sleep study was performed. Their medical treatment had been 
optimized and all their medications were continued throughout 
the study. There were no known electrolyte abnormalities in these 
children and none of them had undergone a prior corrective cardiac 
surgery. All participants underwent an in-lab polysomnographic 
sleep study.
sleep recordIngs
The patients were studied in the Technion Institute of Technology 
Sleep Disorders Center (Haifa, Israel) shortly following arrival to 
the hospital. All children were accompanied by at least one par-
ent throughout the sleep study. During polysomnography (PSG), 
the following variables were continuously measured and recorded: 
two channels of electroencephalogram (C3-A2 and O2-A1), elec-
trooculogram, chin and anterior tibialis electromyograms, chest and 
abdominal wall movement (piezoelectric electrodes), electrocardio-
gram, and air flow (thermistor). Arterial oxygen saturation (SpO2) 
was assessed by pulse oximetry, and end-tidal CO2 (ETCO2) levels by 
capnograph. All measures were digitized using a commercially avail-
able polysomnography system (EEG 4214; Nihon Kohden, Kogyo 
Co, Tokyo, Japan, or Embla system, Flaga hf, Iceland).
Sleep  was  staged  according  to  standard  criteria  (American 
Academy of Sleep Medicine Task Force, 1999). Sleep efficiency 
was calculated as the percentage total sleep time vs. total record-
ing time (time in bed). Arousals from sleep were defined as any www.frontiersin.org  September 2010  | Volume 1  | Article 133  |  3
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to 97.6 ± 6.9 (p < 0.05 for both). Sleep efficiency was low in both 
groups, but total sleep time was significantly lower in children with 
CHF than non-CHF children. None had documented arrhythmias. 
In the infant study group eight had normal RDI (<2) and two 
had and RDI of 7 and 9 (data not shown). Seven of the children 
in the control non-CHF group had sleep apnea, with an average 
RDI of 12.2 ± 3.2 events/hour and a minimal oxygen saturation 
ranges between 82 to 92%. All infants with CHF were irritable 
on admission with reduced appetite and difficulties with feedings 
(four/seven of the infants were fed through a nasogastric tube). All 
children were in the lowest 10 percentile for weight (16.4 ± 7.6 kg 
vs. 24.7 ± 8.8 kg in the age-matched group). Three children had an 
enlarged liver on their physical examination and two had pulmo-
nary congestion and evidence of pleural effusion on chest x-ray. 
Data are summarized in Table 3.
Table 4  demonstrates  the  polysomnographic  characteristics 
of the patients, given by subgroup categorization. Sleep was frag-
mented in most participants, with low sleep efficiency and relatively 
high arousal index, which tended to be higher in the low output 
than high output cardiac failure, but was in both pediatric groups 
significantly lower than in adults with CHF. Of note, the average res-
piratory disturbance index of the adults with CHF was 32.8 ± 5.2/
hour, with those experiencing CSR having higher RDIs than the 
non-CSR individuals. Among both subgroups of children with 
CHF, despite occasional apneas and oxygen desaturations to as low 
as 78% in the high output group and 92% in the low output group, 
as well as arousals from sleep and post arousal hyperpnea, none 
had a typical CSR pattern. Although total sleep time was relatively 
low (almost 3 h in the high output group and almost 5 h in the low 
output group), all patients had at least two cycles of REM–NREM 
sleep (active-quiet sleep in the high output group). Oxygen satura-
tion was lowest during REM (active) sleep in all cases.
dIscussIon
The major novel finding of this study is the absence of CSR among 
10 children with severe heart failure. Given the high prevalence of 
CSR in adults with CHF (40% in our group, up to 50% in others’), 
we believe that the complete absence of this respiratory pattern, 
together with the scarcity of literature regarding CSR in children, 
indicates a substantial age-related effect on the development of 
later stage. The etiology of the heart failure in the adult group was 
ischemic heart disease in 70%, valvular disease in 20% and other 
causes in 10%. All of the patients in the adult group had had a 
heart failure diagnosis for more than a year. The individual clinical 
characteristics of the CHF patients are presented in Table 1.
Medical therapy for heart failure in both CHF groups, the chil-
dren and adults, consisted of angiotensin-converting enzyme inhib-
itors or angiotensin II receptor blockers, diuretics, digoxin, and 
β-blockers (Table 2). When comparing children with and without 
CHF, subjects with CHF were tachypneic and tachycardic during 
stable sleep with an average respiratory rate of 55.1 ± 6.7 breath/min 
compared to 26.9 ± 3, and heart rate of 127.6 ± 8.7 BPM compared 
Table 2 | Characteristic of the CHF patients according to their group.
Variable  Control group 2  Children  CHF children  CHF children 
  (CHF adults)  with CHF  (low output failure group)  (high output failure group)
No.  10  10  3  7
Male/females  7/3  5/5  1/2  4/3
Age (year)  61.9 ± 2.6  3.6 ± 2.1  11.5 ± 4.4*  0.22 ± 0.04
Ejection fraction (%)  26.5 ± 3.1  36.8 ± 4  22 ± 6.8*  43 ± 2.3
Diuretics (%)  60  90  66  100
ACE inhibitors (%)  100  50  66  42
Digoxin (%)  33  60  66  57
β-Blockers (%)  50  10  0  14
Data presented as mean ± SEM.
*p < 0.05 (from other two groups).
Table 1 | Individual cardiac characteristics of participants with CHF.
Patient #  Gender  LVEF%  Etiology of CHF
STudy GRouP-CHF CHILdREn
1  M  39  VSD, PHTN
2  F  40  VSD
3  F  19  Dilated cardiomyopathy
4  M  42  VSD + ASD, PS
5  F  47  VSD
6  M  50  VSD
7  M  35  Dilated cardiomyopathy
8  F  12  Dilated cardiomyopathy
9  M  50  VSD, PHTN
10  F  34  VSD
ConTRoL GRouP-CHF aduLTS
21  M  35  Ischemic cardiomyopathy
22  F  30  Ischemic cardiomyopathy
23  M  20  Ischemic cardiomyopathy
24  M  45  Rheumatic heart disease,   
      recurrent endocarditis
25  F  15  Ischemic cardiomyopathy
26  M  25  Ischemic cardiomyopathy
27  M  15  Valvular heart disease
28  F  20  Valvular heart disease
29  M  35  Ischemic cardiomyopathy
30  M  25  Ischemic cardiomyopathyFrontiers in Psychiatry  |  Sleep Disorders    September 2010  | Volume 1  | Article 133  |  4
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CSR. The other notable finding of this study is the extremely poor 
sleep quality and reduced total sleep time of children with CHF, 
which was a phenomenon previously well known to practicing 
clinicians but lacking in objective data.
The fragmented sleep we observed in children with CHF likely 
results from the continuous respiratory and cardiac distress as indi-
cated by the tachypnea and tachycardia in the study group, along 
with the elevated respiratory workload and pulmonary conges-
tion. Other known factors causing airway obstruction followed 
by sleep fragmentation were excluded in our group of patients as 
RDI score was normal in the vast majority of the children. While 
a great deal has been written about the failure to thrive (FTT) and 
developmental delay of these children secondary to their respira-
tory distress and subsequently difficulties with feeding and low 
caloric intake along with high energy demand, little attention has 
been put on their sleep quality. From the literature regarding chil-
dren with sleep apnea and other sleep disturbances (independent 
of cardiac pathology) we know that poor sleep quality may be 
associated with growth retardation, behavioral problems, and low 
scholastic achievements (Golan et al., 2004). In the current study, 
children with CHF demonstrated significantly reduced total sleep 
time compared to matched control children, even though many of 
them had sleep apnea. We believe that the very poor nocturnal sleep 
of children with CHF may represent a therapeutic target for future 
research with the potential to improve growth and developmental 
delay in afflicted individuals.
There are increasing data showing that in adults CSR may alter 
the natural history of CHF (Lanfranchi et al., 1999; Sin et al., 2000) 
and furthermore, recent evidence suggests that effective treatment 
of CSR in adults improves various aspects of cardiovascular char-
acteristics in patients with CHF and CSR; therefore, an increased 
awareness of these breathing disorders may alter the therapeutic 
approach (Javaheri, 2000; Sin et al., 2000; Bradley et al., 2005).
When studying patients with high and low output heart failure 
we aimed to better learn about the impact of circulation delay, 
because the association between increased circulation time and 
CSR is not clear at this time. Stability or instability in ventilatory 
control is generally described using loop gain, an engineering term 
to describe the instability in a negative feedback control system 
(Younes et al., 2001). A high loop gain refers to an unstable control 
system (i.e., prone to periodic breathing) whereas a low loop gain 
describes a stable control system (i.e., not susceptible to periodic 
breathing) (Wellman et al., 2007). Loop gain can be considered 
the product of multiple different gains including central drive (i.e., 
chemoresponsiveness or controller gain), the efficiency of CO2 
excretion (i.e., plant gain), and the delays caused by the circulation 
and hemoglobin binding affinity (i.e., mixing gain) (Malhotra and 
Jordan, 2006; Eckert et al., 2007). In humans, the relative impact of 
the various gains is difficult to test experimentally (Stanchina et al., 
2007); therefore we thought the study of children would provide a 
unique opportunity to understand the importance of the various 
factors in control of breathing.
Initial reports observed prolonged circulation time in patients 
with CHF and CSR, hypothesizing that a delay in the transport of 
oxygenated blood to the brain or the carotid chemoreceptors is 
responsible for the development of CSR (Ryan and Bradley, 2005). 
CSR has been reported to be related to an increased circulation time 
Table 3 | Baseline characteristics and polysomnographic characteristics 
of the pediatric patients according to their group.
Variable  Control group 1  CHF children 
  (children w/o  (n = 10)  p 
  CHF) (n = 10)
Male/females  4/6  5/5  0.67
Age (year)  3.7 ± 2  3.6 ± 2.1  0.96
Height (cm)  82 ± 12  81.2 ± 14.2  0.97
Weight (kg)  24.7 ± 8.8  16.4 ± 7 .6  0.50
Total sleep  373 ± 16  195 ± 49  0.001 
time (min)
Sleep   72.3 ± 2.4  65.6 ± 6  0.37 
efficiency (%)
Arousal index  9.4 ± 1.3  9.2 ± 2.5  0.96 
(no./h)
Stage 1–2   60.9 ± 5.2  58.5 ± 10.3  0.81 
(% of total sleep 
period time)
Stage 3–4  20.4 ± 5.1  20.3 ± 10.6  0.99 
 (% of total sleep 
period time)
REM sleep (%)  18.2 ± 2.1  20.3 ± 6.5  0.70
Prevalence of   0  0  N/A 
CSA-CSR (%)
Respiratory rate  26.9 ± 3  55.1 ± 6.7  0.0012
Heart rate  97 .6 ± 6.9  127 .6 ± 8.7  0.017
Data presented as mean ± SEM.
REM,  rapid  eye  movement;  CSA-CSR,  central  sleep  apnea-Cheyne–Stokes 
respiration.
Table 4 | Baseline characteristics and polysomnographic characteristics 
of the CHF patients according to their group.
Variable  CHF children  CHF children  Control group 2 
  (low output  (high output  (CHF adults) 
  failure group)  failure group)
Total sleep  280 ± 99  160 ± 55*  272 ± 23 
time (min)
Sleep   69 ± 4  64 ± 8  72.2 ± 4 
efficiency (%)
Arousal  14 ± 4.5  7 ± 2*  19 ± 2.7 
index (no./h)
Prevalence of   0  0  40* 
CSA-CSR (%)
Wake   SaO2 (%)  96 ± 1  95.5 ± 2.4  93 ± 0.7
Mean   SaO2 (%)  97 ± 2  91 ± 3.8  89.3 ± 1.7
Mean   SaO2   94 ± 2  92 ± 3  86 ± 4 
nadirs (%)
ETCO2  40 ± 2  38 ± 1  38 ± 4
Data presented as mean ± SEM.
 SaO2,  oxygen  saturation;  CSA-CSR,  central  sleep  apnea-Cheyne–Stokes 
respiration; ETCO2, end-tidal CO2.
*p < 0.05 (from other two groups).www.frontiersin.org  September 2010  | Volume 1  | Article 133  |  5
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Down’s syndrome, and had obstructive apneas, yet did not have 
CSR. Sommers et al. (2005) reported CHF in 70.6% of infants with 
severe heart disease during the first year of life with the condition 
lasting for a mean of 15 months. In 78% of patients with congenital 
heart disease (CHD), CHF ended after an operation as happened 
with our group of infants with CHD. In adults, CSR develops fol-
lowing a chronic prolonged course of heart failure. The relatively 
shorter course of the disease in children (up to corrective surgery 
or spontaneous improvement) may be therefore another factor 
accounting for the absence of CSR. Additional potential factors may 
include the underlying cause for the CHF and better ventricular 
compliance in the infant.
One could debate whether the well reported periodic breath-
ing of the neonate is an immature form of CSR or has a similar 
appearance of the crescendo-decrescendo pattern of CSR. Since 
periodic breathing of the neonate is common in premature new-
borns (especially those born around gestational age of 30 weeks) but 
much less frequent in term infants, it may represent an immature 
respiratory control system, while in CSR the respiratory control 
sensitivity is usually increased. In term newborns, periodic breath-
ing of the neonate has been reported in up to 3% of total sleep time 
at age 2 months, and less than 1% at 5 months of age (Parmelee 
et al., 1972). Furthermore, while periodic breathing of the neonate 
worsens during active (REM) sleep (Oliveira et al., 2004), this is 
usually not the case in CSR. In addition, while in periodic breath-
ing, arousals from sleep may be absent, in CSR they appear dur-
ing the peak hyperpneic phase of breathing (Javaheri et al., 1998; 
Naughton and Bradley, 1998; Sin et al., 1999; Weintraub et al., 2001; 
Bradley and Floras, 2003; Oliveira et al., 2004). Thus, although 
these two respiratory patterns may have some common features, 
they likely result from different mechanisms and pathophysiolo-
gies, and indeed despite considerable research regarding periodic 
breathing of the neonate, it has never been associated with CHF. 
In our cohort, all infants were born at term, and although they 
experienced occasional apneas they did not meet criteria to be clas-
sified as periodic breathing (at least three consecutive apneas of at 
least 3 s duration each, separated by intervals not longer than 20 s) 
(Parmelee et al., 1972). It would appear that in any case periodic 
breathing and CSR represent different phenomena, with periodic 
breathing expressing a form of immature respiratory control mani-
fested predominantly during active sleep, and not related to heart 
failure, while CSR results from either heart failure or other diseases 
(e.g., neurological damage) via a mechanism which still needs to 
be better understood.
Our study has several limitations. First, our sample size is rela-
tively small. However, since we observed zero CSR despite substan-
tial CHF, and aside from one case, CSR has not been previously 
reported in children despite a relatively large number of studies on 
CHF, we believe that indeed CSR is an exclusively adult phenom-
enon as confirmed in our study. Clearly more studies are needed to 
prove conclusively this statement, and to identify potential protec-
tive mechanisms in children with CHF. Second, only three of our 
patients had low output CHF. As far as we know, even in adults, high 
output CHF (such as in hyperthyroidism) has not been associated 
with CSR. Thus, again, larger scale studies are required in order to 
characterize the absence of CSR in various subgroups of children 
with CHF. Third, we have assessed respiration with thermistors 
from the lung to the carotid body (i.e., mixing gain) and has been 
shown to correlate inversely to cardiac output (Hall et al., 1996). 
However, trying to test this experimentally, Crowell et al. (1956) had 
to lengthen the heart to brain circulation time by several minutes in 
order to induce CSR. Furthermore, despite this extreme prolonga-
tion in circulation time, CSR was observed only in about 30% of 
the animals. Thus, prolonged circulation time alone is unlikely to 
result in CSR, and if it does so, only along with additional factors 
which were not addressed in out study.
Hudgel and Hamilton (1994) have demonstrated an important 
role of upper airway instability in CSR with much of the variability 
in tidal volume explainable based on fluctuations in upper airway 
resistance. Because the upper airway is much more stable in children 
than adults (Marcus et al., 2005), the absence of CSR in children 
with CHF may support the importance of dynamic upper airway 
instability in CSR pathogenesis.
A number of studies have investigated the risk factors for the 
presence of central sleep apnea in adult patients with CHF. Sin et al. 
(1999) identified the following risk factors in men and women with 
CHF: male gender, atrial fibrillation, age >60 years, and hypocap-
nia (PCO2 < 38 mmHg) during wakefulness. In our children with 
CHF 50% were males, no arrhythmias were recorded, and dur-
ing sleep recording sporadic hypocapnic events did not result in 
CSR. Although our sample was small, the complete absence of CSR 
despite severe CHF in these children suggests that age is a strong 
determinant of CSR across all age groups. Several other studies have 
reported on the potential age-related effect on the development of 
CSR in patients with heart failure. Mared et al. (2004) have shown 
that CSR is common in elderly patients hospitalized due to decom-
pensated chronic heart failure and that age is a stronger determi-
nant of CSR than any of the cardiac or other clinical variables. As 
age is a strong predictor of CSR, this may reflect the underlying 
age-dependency of sleep apnea found in healthy subjects as dem-
onstrated by Bixler et al. (1998), although the prevalence is much 
lower than that found in patients with heart failure.
Compared with younger CHF patients, older patients tend to 
have less compliant left ventricles with higher left ventricular filling 
pressures, as well as an increased prevalence of pulmonary venous 
hypertension. The idea of CSR mainly being a function of low 
cardiac output (as estimated by LVEF) may therefore be an over-
simplification (Sin et al., 1999; Mared et al., 2004). Furthermore 
prevalence differences of CSR between studies could result from 
the age of the population studied, with 40% prevalence in our 
adult study group with average age of 61.9 ± 2.6 years while there 
are reports in the literature of prevalence of up to 70%, for exam-
ple in a small group of elderly, hospitalized patients (Ancoli-Israel 
et al., 1994; Mared et al., 2004). Due to age restrictions or other 
selection criteria, the importance of age may have been underesti-
mated in many previous studies regarding factors associated with 
CSR. Thus, we speculate that the absence of CSR in children and 
its high prevalence in adults is strongly affected by the young age 
of the population we studied, although the duration of CHF may 
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Nevertheless, despite these limitations, we believe our study 
  suggests that CSR is an adult phenomenon. Although our patients 
demonstrated the classical factors believed to drive CSR such as low 
output cardiac failure, pulmonary congestion, hypoxemic events, 
arousals from sleep and hypocapnia, none of the children had CSR 
while 40% of the adults did. Thus, we speculate that regardless of 
the exact mechanism which drives CSR, age (via CHF duration or 
upper airway stability) is an over-riding factor.
and not nasal pressure. Theoretically since this is a less sensitive 
method we could have missed CSR, although we believe this is 
unlikely. Finally, our control groups consisted of adults with CHF 
and children with sleep disordered breathing but not of normal 
healthy children. Since we aimed at investigating potential CSR 
in children with CHF, we believe that their sleep apnea did not 
impose a problem for this specific study since they did not have 
any heart disease.